BAP1-associated uveal melanomas are diagnosed in the age of 30–59 years and are associated with cutaneous melanomas and renal cell carcinomas, while EIF1AX gene variants are associated with thyroid and ovarian cancer [13, 15]. Here, BAP1 is linked to ovarian carcinoma.